Rankings
▼
Calendar
DXCM Q1 2022 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena
DXCM
DexCom, Inc.
$27B
Q1 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$629M
+24.5% YoY
Gross Profit
$398M
63.3% margin
Operating Income
$41M
6.6% margin
Net Income
$97M
15.5% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
-9.9%
Cash Flow
Operating Cash Flow
$71M
Free Cash Flow
-$31M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$5.1B
Total Liabilities
$2.9B
Stockholders' Equity
$2.2B
Cash & Equivalents
$716M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$629M
$505M
+24.5%
Gross Profit
$398M
$344M
+15.8%
Operating Income
$41M
$46M
-10.0%
Net Income
$97M
$40M
+141.4%
Geographic Segments
UNITED STATES
$451M
72%
Non-US
$178M
28%
← FY 2022
All Quarters
Q2 2022 →